Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
American Journal of Surgery|September 22, 2022
Higher SUVmax on FDG-PET is associated with shorter survival in adrenocortical carcinomaSean M Wrenn, Alessandra L Moore, Hina J Shah, et al.
The Journal of Clinical Endocrinology and Metabolism|February 13, 2024
Nonoperative, Active Surveillance of Larger Malignant and Suspicious Thyroid NodulesBenjamin Altshuler, Athanasios Bikas, Theodora Pappa, et al.
American Journal of Surgery|April 3, 2010
Surgical drains can be safely avoided in lateral neck dissections for papillary thyroid cancerMichal Mekel, Antonia E Stephen, Randall D Gaz, et al.
Endocrine Pathology|March 9, 2017
The Flip Side of NIFTP: an Increase in Rates of Unfavorable Histologic Parameters in the Remainder of Papillary Thyroid CarcinomasKristine S Wong, Kyle C Strickland, Trevor E Angell, et al.
Surgery|December 6, 2011
Thyroid-specific knockout of the tumor suppressor mitogen-inducible gene 6 activates epidermal growth factor receptor signaling pathways and suppresses nuclear factor-κB activityChi-Iou Lin, Justine A Barletta, Matthew A Nehs, et al.
The Oncologist|March 1, 2011
Targeting BRAFV600E with PLX4720 displays potent antimigratory and anti-invasive activity in preclinical models of human thyroid cancerCarmelo Nucera, Matthew A Nehs, Sushruta S Nagarkatti, et al.
Thyroid : Official Journal of the American Thyroid Association|November 4, 2020
Papillary Thyroid Carcinoma with High-Grade Features Versus Poorly Differentiated Thyroid Carcinoma: An Analysis of Clinicopathologic and Molecular Features and OutcomeKristine S Wong, Fei Dong, Milhan Telatar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2021
Oncogenic Mutations in PI3K/AKT/mTOR Pathway Effectors Associate with Worse Prognosis in BRAF -Driven Papillary Thyroid Cancer PatientsTheodora Pappa, Sara Ahmadi, Ellen Marqusee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2023
Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic OutcomesAthanasios Bikas, Sara Ahmadi, Theodora Pappa, et al.
Histopathology|December 8, 2019
A potential diagnostic pitfall for hobnail variant of papillary thyroid carcinomaKristine S Wong, Tiffany Y Chen, Sara E Higgins, et al.
Pageof 6